Annual Drug Patent Expirations for VENCLEXTA
Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for VENCLEXTA.
This drug has two hundred and thirty-one patent family members in forty-two countries.
The generic ingredient in VENCLEXTA is venetoclax. One supplier is listed for this compound. Additional details are available on the venetoclax profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
